Compare IOVA & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | LGIH |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 1.0B |
| IPO Year | N/A | 2013 |
| Metric | IOVA | LGIH |
|---|---|---|
| Price | $2.39 | $53.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 6 |
| Target Price | $10.45 | ★ $75.90 |
| AVG Volume (30 Days) | ★ 12.6M | 441.3K |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.53 |
| Revenue | $250,425,000.00 | ★ $1,788,933,000.00 |
| Revenue This Year | $60.71 | N/A |
| Revenue Next Year | $59.52 | $18.60 |
| P/E Ratio | ★ N/A | $11.86 |
| Revenue Growth | ★ 175.62 | N/A |
| 52 Week Low | $1.64 | $39.70 |
| 52 Week High | $6.50 | $97.25 |
| Indicator | IOVA | LGIH |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 67.53 |
| Support Level | $2.29 | $41.97 |
| Resistance Level | $2.80 | $53.99 |
| Average True Range (ATR) | 0.18 | 2.53 |
| MACD | -0.05 | 1.37 |
| Stochastic Oscillator | 13.57 | 86.59 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.